RBBP6 promotes human cervical carcinoma malignancy via JNK signaling pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

RBBP6 promotes human cervical carcinoma malignancy via JNK signaling pathway

Published:2018-05 Issue: Volume:101 Page:399-405
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Teng Fang,Ruan Hong-Jie,Xu Juan,Ni Jing,Qian Bing,Shen Rong,Gao Ling-Juan

Funder

National Natural Science Foundation of China

Natural Science Foundation of Jiangsu Province

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference23 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int. J. Cancer,2015

2. Global strategies for cervical cancer prevention;Pimple;Curr. Opin. Obstet. Gynecol.,2016

3. Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a gynecologic oncology group study;Monk;J. Clin. Oncol.,2009

4. Advances in diagnosis and treatment of metastatic cervical cancer;Li;J. Gynecol. Oncol.,2016

5. PACT: cloning and characterization of a cellular p53 binding protein that interacts with Rb;Simons;Oncogene,1997

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RBBP6 maintains glioblastoma stem cells through CPSF3-dependent alternative polyadenylation;Cell Discovery;2024-03-19

2. Cannabis sativa a Potential Anticancer Treatment in Melanoma Cancer Cells;Natural Product Communications;2023-09

3. Candidate Genes and Pathways in Cervical Cancer: A Systematic Review and Integrated Bioinformatic Analysis;Cancers;2023-01-30

4. Abnormal Expression of Long Non-Coding RNA FGD5-AS1 Affects the Development of Ovarian Cancer Through Regulating miR-107/RBBP6 Axis;Chinese Journal of Physiology;2023

5. The E3 Ligases in Cervical Cancer and Endometrial Cancer;Cancers;2022-10-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3